Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 8 of 8

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2017

Hypoxia and VEGF overexpression induce the formation of labyrinth capillaries, which are described to be responsible for leakage in wet AMD

Antje Kristina Biesemeier; Shan Liu; Marina Tikhonovich; Guido Hartmann; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2264.

ARVO Annual Meeting Abstract September 2016

What is the biologically relevant K D for VEGF binding to ranibizumab in the eye? A comparison of in-vivo and in-vitro estimates.

Norman Mazer; Dietmar Schwab; Laurence Hutton-Smith; Helen M Byrne; Eamonn A Gaffney; Philip Maini; Guido Hartmann; Joerg Moelleken; Christian Gassner; Joerg Thomas Regula

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3327.

ARVO Annual Meeting Abstract September 2016

Barrier function studies of VEGF and ANG-2 in human endothelial cells

Guido Hartmann

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3217.

ARVO Annual Meeting Abstract September 2016

Quantitative assessment of vessel regression and pericyte detachment in a mouse model of retinal angiogenesis

Sabine Uhles; Franco Revelant; Sabine Grüner; Guido Hartmann; Fethallah Benmansour

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4534.

ARVO Annual Meeting Abstract September 2016

Levels of vitreous angiopoietin-2 are associated with vitreous levels of inflammatory cytokines in patients with age-related macular degeneration or diabetic retinopathy

Everson Nogoceke; Gonzalo Durán-Pacheco; Gabriella Widmer; Paolo Piraino; Michael Koss; Guido Hartmann

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4813.

ARVO Annual Meeting Abstract September 2016

Lysophosphatidic Acids and Autotaxin in Retinal Vein Occlusion

Ivanka Dacheva; Christoph Ullmer; Karolina Ceglowska; Everson Nogoceke; Katarzyna Nowomiejska; Stephan Müller; Guido Hartmann; Gonzalo Durán-Pacheco; Florian Kretz; Gerd U. Auffarth; Michael Koss

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5354.

ARVO Annual Meeting Abstract April 2014

Anti -VEGF/Ang2 bi-specific antibody ameliorates endotoxin-induced uveitis in mice

Daiju Iwata; Peter Lundh von Leithner; Yin Shan Eric Ng; Guido Hartmann; David T Shima

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2354.

ARVO Annual Meeting Abstract April 2014

Bispecific anti-VEGF/ANG2 antibody exhibits superior efficacy to VEGF monotherapy in a model of spontaneous CNV

Peter Lundh von Leithner; Daiju Iwata; Y. Ng; Jorg Regula; Guido Hartmann; David T Shima

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2356.

Advertisement